-+ 0.00%
-+ 0.00%
-+ 0.00%

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE PRESENTATIONS OF CLINICAL DATA FROM STUDIES OF ZOREVUNERSEN, AN INVESTIGATIONAL MEDICINE FOR THE TREATMENT OF DRAVET SYNDROME, AT THE 16TH EUROPEAN EPILEPSY CONGRESS (EEC)

Reuters·09/01/2026 11:30:00

Please log in to view news